Scientific Sessions 2024  /  Gene Therapy in the Cardiology Clinic: Ready for Prime Time?  /  So How Do We Determine the Right Strategy for the Right Patient?
Logo

American Heart Association

  107
  0

Final ID:

So How Do We Determine the Right Strategy for the Right Patient?

  • Watkins, Hugh  ( University of Oxford , Oxford , United Kingdom )
  • Seidman, Christine  ( HARVARD MEDICAL SCHOOL , Boston , Massachusetts , United States )
    • Author Disclosures:
    Hugh Watkins: DO have relevant financial relationships ; Consultant:Cytokinetics:Active (exists now) ; Consultant:BridgeBio:Past (completed) ; Consultant:BioMarin:Active (exists now) | Christine Seidman: DO have relevant financial relationships ; Consultant:Maze:Active (exists now) ; Other (please indicate in the box next to the company name):Merck - Board of Directors:Active (exists now) ; Advisor:Burroughs Wellcome Fund:Active (exists now) ; Consultant:BridgeBio:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Gene Therapy in the Cardiology Clinic: Ready for Prime Time?

Monday, 11/18/2024 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
Gene Therapy for Lysosomal Storage Disorders: From the Bench to the Bedside

Adler Eric, Greenberg Barry

Gene Silencing: Targeting TTR in Amyloidosis as a Paradigm for Knocking Down Mutant Alleles

Alexander Kevin, Garcia-pavia Pablo

More abstracts from these authors:
Gene Therapy: The Next Frontier or Fool's Gold?

Seidman Christine, Watkins Hugh

The Braunwald Lecture

Watkins Hugh

You have to be authorized to contact abstract author. Please, Login
Not Available